This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cosma, M. P.
Right arrow Articles by Colantuoni, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cosma, M. P.
Right arrow Articles by Colantuoni, V.

 Previous Article  |  Next Article 

Mol Cell Biol, June 1998, p. 3321-3329, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Mutations in the Extracellular Domain Cause RET Loss of Function by a Dominant Negative Mechanism

Maria Pia Cosma,1 Monica Cardone,1 Francesca Carlomagno,2 and Vittorio Colantuoni1,3,*

Dipartimento di Biochimica e Biotecnologie Mediche and Centro di Ingegneria Genetica, CEINGE,1 and Centro di Endocrinologia e Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università di Napoli "Federico II",2 Naples, and Facoltà di Farmacia, Università di Reggio Calabria, Catanzaro,3 Italy

Received 26 February 1998/Accepted 19 March 1998

The RET proto-oncogene encodes a tyrosine kinase receptor expressed in neuroectoderm-derived cells. Mutations in specific regions of the gene are responsible for the tumor syndromes multiple endocrine neoplasia types 2A and 2B (MEN 2A and 2B), while mutations along the entire gene are involved in a developmental disorder of the gastrointestinal tract, Hirschsprung's disease (HSCR disease). Two mutants in the extracellular domain of RET, one associated with HSCR disease and one carrying a flag epitope, were analyzed to investigate the impact of the mutations on RET function. Both mutants were impeded in their maturation, resulting in the lack of the 170-kDa mature form and the accumulation of the 150-kDa immature form in the endoplasmic reticulum. Although not exposed on the cell surface, the 150-kDa species formed dimers and aggregates; this was more pronounced in a double mutant bearing a MEN 2A mutation. Tyrosine phosphorylation and the transactivation potential were drastically reduced in single and double mutants. Finally, in cotransfection experiments both mutants exerted a dominant negative effect over protoRET and RET2A through the formation of a heteromeric complex that prevents their maturation and function. These results suggest that HSCR mutations in the extracellular region cause RET loss of function through a dominant negative mechanism.


* Corresponding author. Mailing address: Dipartimento di Biochimica e Biotecnologie Mediche, Facoltà di Medicina e Chirurgia, Università di Napoli, "Federico II," Via Sergio Pansini, 5, 80131 Naples I, Italy. Phone: 39 81 746 3735. Fax: 39 81 746 3074. E-mail: colantuoni{at}dbbm.unina.it.


Mol Cell Biol, June 1998, p. 3321-3329, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Freche, B., Guillaumot, P., Charmetant, J., Pelletier, L., Luquain, C., Christiansen, D., Billaud, M., Manie, S. N. (2005). Inducible Dimerization of RET Reveals a Specific AKT Deregulation in Oncogenic Signaling. J. Biol. Chem. 280: 36584-36591 [Abstract] [Full Text]  
  • Weber, F., Eng, C. (2005). Editorial: Germline Variants within RET: Clinical Utility or Scientific Playtoy?. J. Clin. Endocrinol. Metab. 90: 6334-6336 [Full Text]  
  • Lui, V. C.H., Leon, T. Y.Y., Garcia-Barcelo, M.-M., Ganster, R. W., Chen, B. L.S., Hutson, J. M., Tam, P. K.H. (2005). Novel RET Mutation Produces a Truncated RET Receptor Lacking the Intracellular Signaling Domain in a 3-Generation Family with Hirschsprung Disease. Clin. Chem. 51: 1552-1554 [Full Text]  
  • Jijiwa, M., Fukuda, T., Kawai, K., Nakamura, A., Kurokawa, K., Murakumo, Y., Ichihara, M., Takahashi, M. (2004). A Targeting Mutation of Tyrosine 1062 in Ret Causes a Marked Decrease of Enteric Neurons and Renal Hypoplasia. Mol. Cell. Biol. 24: 8026-8036 [Abstract] [Full Text]  
  • Garcia-Barcelo, M-M, Sham, M-H, Lui, V C-H, Chen, B L-S, Song, Y-Q, Lee, W-S, Yung, S-K, Romeo, G, Tam, P K-H (2003). Chinese patients with sporadic Hirschsprung's disease are predominantly represented by a single RET haplotype. J. Med. Genet. 40: e122-122 [Full Text]  
  • Kjaer, S., Ibanez, C. F. (2003). Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET. Hum Mol Genet 12: 2133-2144 [Abstract] [Full Text]  
  • Mardy, S., Miura, Y., Endo, F., Matsuda, I., Indo, Y. (2001). Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor. Hum Mol Genet 10: 179-188 [Abstract] [Full Text]  
  • Quadro, L., Fattoruso, O., Cosma, M. P., Verga, U., Porcellini, A., Libroia, A., Colantuoni, V. (2001). Loss of Heterozygosity at the RET Protooncogene Locus in a Case of Multiple Endocrine Neoplasia Type 2A. J. Clin. Endocrinol. Metab. 86: 239-244 [Abstract] [Full Text]  
  • Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K.-M., Johnson, M., Lynch, D., Tsien, R. Y., Lenardo, M. J. (2000). Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations. Science 288: 2354-2357 [Abstract] [Full Text]  
  • Anders, J., Kjar, S., Ibanez, C. F. (2001). Molecular Modeling of the Extracellular Domain of the RET Receptor Tyrosine Kinase Reveals Multiple Cadherin-like Domains and a Calcium-binding Site. J. Biol. Chem. 276: 35808-35817 [Abstract] [Full Text]